Effect of fusidic acid on the hepatic cytochrome P450 enzyme system

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 11, 1999, Pages 562-566

  Reimann, G ^b   Barthel, B ^b   Rockstroh, J K ^b   Spatz, D ^b   Brockmeyer, N H ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b NONE

Author keywords

AIDS; Anti pyrine pharmacokinetics; Cytochrome P450; Fusidic acid

Indexed keywords

3 HYDROXYMETHYLPHENAZONE; 4 HYDROXYPHENAZONE; CYTOCHROME P450; DRUG METABOLIZING ENZYME; FUSIDIC ACID; LEVOMETHADONE; NORPHENAZONE; PHENAZONE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG EFFECT; DRUG HALF LIFE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ANTI-BACTERIAL AGENTS; ANTIPYRINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME ACTIVATION; FUSIDIC ACID; HIV SEROPOSITIVITY; HUMANS; LIVER; METHADONE; MORPHINE DEPENDENCE; NARCOTICS; TIME FACTORS;

EID: 0032747843     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Brockmeyer NH, Tillmann I, Mertins L, Barthel B, Goos M 1997 Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients. Pharmacol Eur Med Res 29: 377-383
2. Brockmeyer NH, Mertins L, Goos M 1991 Pharmacokinetic interaction of antimicrobial agents with levomethadone in drug-addicted AIDS patients. Klin Wochenschr 69: 16-18
3. Brown KN, Percival A 1978 Penetration of antimicrobials into tissue culture cells and leukocytes. Scand J Infect Dis 14: 251-260
4. Chadwick AJ, Jackson B 1969 Intraocular penetration of the antibiotic fucidin. Br J Ophtalmol 53: 26-29
5. Degre M, Beck S 1994 Anti-HIV activity of didesoxynucleosides, foscarnet, and fusidic acid is potentiated by human leukocyte interferon in blood-derived macrophages. Chemotherapy 40: 201-208
6. Deodar SD, Russel F, Dick WC, Nuki G, Buchanan WW 1972 Penetration of sodium fusiate Fucidin in the synovial cavity. Scand J Rheumatol 1: 33-39
7. Eichelbaum M, Sonntag B, Dengler HJ 1981 HPLC determination of antipyrine metabolites. Pharmacology 23: 192-202
8. Eichelbaum M, Spannbrucker N 1977 Rapid and sensitive method for the determination of antipyrine in biological fluids by high-pressure liquid chromatography. J Chromatogr 140: 288-292
9. Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M 1996 Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxy-antipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin Pharmacol Ther 59: 613-623
10. Forsgreen, A, Bellahsene, A 1985 Antibiotic accumulation in human polymorpho-nuclear leucocytosis and lymphocytes. Scand J Infect Dis 44: 16-23
11. Godtfredsen W, Roholt K, Tybring L 1962 Fucidin. A new orally antibiotic. Lancet 1: 928-931
12. Godtfredsen WO, Vangedal S 1966 On the metabolism of fusidic acid in man. Acta Chem Scand 20: 1599-1607
13. Guettler F, Trebing L 1971 Interaction of albumin with fusidic acid. Br J Pharmacol 43: 151-160
14. Hording M, Christensen KC, Faber V 1990 Fusidic acid treatment of HIV infection: No significant effect in a pilot trial. Scand J Infect Dis 22: 649-652
15. Iribane C, Berthou F, Baird S, Dreano Y, Picart Bail JP, Beaune P, Menez JF 1996 Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 9: 365-373
16. Iribane C, Dreano Y, Bardou LG, Menez JF, Berthou F 1997 Interaction of methadone with substrates of human hepatic cytochrome P450 3A4. Toxicology 117: 13-23
17. Kempf DJ, Marsh KC, Kumar G, Rodrigues AD, Denissen JF, McDonald E, Kukulka MJ, Hsu A, Granneman GR, Baroldi PA, Sun E, Pizzuti D, Platter JJ, Norbeck DW, Leonard JM 1997 Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrob Agents Chemother 41: 654-660
18. Ohnhaus EE, Brockmeyer NH, Dylewicz P, Habicht H 1987 The effect of antipyrine and rifampicin on the metabolism of diazepam. Clin Pharmacol Ther 42: 148-156
19. Park BK, Knitteringham NR, Pirmohamed M, Tucker GT 1996 Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications. Br J Clin Pharmacol 41: 477-491
20. Reeves DS 1987 The pharmacokinetics of fusidic acid (Review). J Antimicrob Chemother 20: 467-476
21. Sachs L 1984 Statistische Auswertungsmethoden. Springer, Heidelberg
22. Sattar MA, Barrett SP, Cawley MID 1983 Concentrations of some antibiotics in synovial fluid after oral administration with special reference to antistaphylococcal activity. Ann Rheum Dis 42: 67-74
23. Sorensen B, Serjyen P, Thomsen M 1966 Fucidin, pro-staphlin, and penicillin concentrations in burn crusts. Acta Chir Scand 131: 423-429
24. Vereby K, Volauka J, Mule S, Resnick R 1975 Methadon in man: Pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharmacol Ther 18: 180-190
25. Vesell ES1979 The antipyrine test in clinical pharmacology: Conceptions and misconceptions. Clin Pharmacol Ther 26: 275-286
26. Wagner JG 1975 Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, IL
27. Williamson J, Russell F, Doig WM, Paterson RWW 1970 Estimation of sodium fusidate and fusidic acid. Br J Ophtalmol 54: 126-130
28. Wise R, Pippard M, Mitchard M 1977 The disposition of sodium fusiate in man. Br J Clin Pharmacol 4: 615-619
29. Youle MS, Hawkins DA, Lawrence AG, Tenant-Flowers M, Shanson DC, Gazzard BG 1989 Clinical, immunological, and virological effects of sodium fusiate in patients with AIDS or AIDS-related complex (ARC): An open study. J AIDS 2: 59-62